Catalytic iron and acute kidney injury.
暂无分享,去创建一个
[1] G. Mufti,et al. Bleomycin‐detectable iron in serum from leukaemic patients before and after chemotherapy Therapeutic implications for treatment with oxidant‐generating drugs , 1988, FEBS letters.
[2] S. Shah,et al. Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. , 1988, The Journal of clinical investigation.
[3] M. Paller. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. , 1988, The American journal of physiology.
[4] B. Hedlund,et al. Role of iron in postischemic renal injury in the rat. , 1988, Kidney international.
[5] P. Menasché,et al. Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. , 1988, The Journal of thoracic and cardiovascular surgery.
[6] P. Menasché,et al. Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans. , 1990, Circulation.
[7] B. Halliwell,et al. Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.
[8] J. Eaton,et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. , 1992, The Journal of biological chemistry.
[9] G. Vercellotti,et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. , 1992, The Journal of clinical investigation.
[10] R. Zager. Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. , 1992, The Journal of clinical investigation.
[11] S. Shah,et al. Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. , 1993, The Biochemical journal.
[12] Steven S. Vogel,et al. Using Caged Calcium to Study Sea Urchin Egg Cortical Granule Exocytosis in Vitro , 1994 .
[13] B. Halliwell,et al. Measurement of iron and copper in biological systems: bleomycin and copper-phenanthroline assays. , 1994, Methods in enzymology.
[14] S. Shah,et al. Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. , 1996, Kidney international.
[15] R. Hotchkiss,et al. Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. , 1997, Surgery.
[16] J. Olson,et al. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin , 1998, Nature Biotechnology.
[17] S. Shah,et al. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. , 1998, Kidney international.
[18] R. P. Cochran,et al. Acute renal failure after cardiopulmonary bypass in related to decreased serum ferritin levels. , 1999, Journal of the American Society of Nephrology : JASN.
[19] P. Ponka. Cell biology of heme. , 1999, The American journal of the medical sciences.
[20] M. Burkitt,et al. A simple, highly sensitive and improved method for the measurement of bleomycin-detectable iron: the 'catalytic iron index' and its value in the assessment of iron status in haemochromatosis. , 2001, Clinical science.
[21] J. Eaton,et al. Pro-oxidant and cytotoxic effects of circulating heme. , 2002, Blood.
[22] P. Guyre,et al. Increase in plasma and surface CD163 levels in patients undergoing coronary artery bypass graft surgery. , 2003, Atherosclerosis.
[23] A. Kausz,et al. Predictors of ARF after cardiac surgical procedures. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] Z. Cabantchik,et al. Labile plasma iron in iron overload: redox activity and susceptibility to chelation. , 2003, Blood.
[25] M. Mitsnefes,et al. J Am Soc Nephrol 15: 3073–3082, 2004 Amelioration of Ischemic Acute Renal Injury by Neutrophil , 2004 .
[26] W. Buurman,et al. Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury1 , 2004, Transplantation.
[27] Joseph V Bonventre,et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.
[28] D. Tsiapras,et al. Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance. , 2005, European heart journal.
[29] E. McCarthy,et al. Declining mortality in patients with acute renal failure, 1988 to 2002. , 2006, Journal of the American Society of Nephrology : JASN.
[30] P. Buehler,et al. CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. , 2006, Blood.
[31] C. Rapisarda,et al. Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera , 2007, JBIC Journal of Biological Inorganic Chemistry.
[32] S. Waikar,et al. The incidence and prognostic significance of acute kidney injury. , 2007, Current opinion in nephrology and hypertension.
[33] André M. N. Silva,et al. Influence of non-enzymatic post-translation modifications on the ability of human serum albumin to bind iron. Implications for non-transferrin-bound iron speciation. , 2009, Biochimica et biophysica acta.
[34] A. Coutinho,et al. Heme oxygenase-1 affords protection against noncerebral forms of severe malaria , 2009, Proceedings of the National Academy of Sciences.
[35] M. Podinovskaia,et al. Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin‐bound iron , 2010, Annals of the New York Academy of Sciences.
[36] Sudhir V. Shah,et al. The role of catalytic iron in acute kidney injury. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[37] P. Buehler,et al. Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. , 2012, The Journal of clinical investigation.
[38] P. Brissot,et al. Non-transferrin bound iron: a key role in iron overload and iron toxicity. , 2012, Biochimica et biophysica acta.
[39] L. Vesterlund,et al. Macrophage expression of LRP1, a receptor for apoptotic cells and unopsonized erythrocytes, can be regulated by glucocorticoids. , 2012, Biochemical and biophysical research communications.
[40] F. Dal-Pizzol,et al. The Effects of N‐Acetylcysteine and Deferoxamine on Plasma Cytokine and Oxidative Damage Parameters in Critically Ill Patients With Prolonged Hypotension: A Randomized Controlled Trial , 2012, Journal of clinical pharmacology.
[41] M. Rajapurkar,et al. Impact of catalytic iron on mortality in patients with acute coronary syndrome exposed to iodinated radiocontrast-The Iscom Study. , 2013, American heart journal.
[42] Anupam Agarwal,et al. Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. , 2013, The Journal of clinical investigation.
[43] Comparison of Bleomycin-Detectable Iron and Labile Plasma Iron Assays , 2013 .
[44] P. Buehler,et al. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. , 2013, Blood.
[45] D. Swinkels,et al. Iron metabolism in the pathogenesis of iron-induced kidney injury , 2013, Nature Reviews Nephrology.
[46] D. Leaf,et al. Plasma catalytic iron, AKI, and death among critically ill patients. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[47] C. Geisler,et al. Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation. , 2014, Blood.
[48] Z. Cabantchik. Labile iron in cells and body fluids: physiology, pathology, and pharmacology , 2014, Front. Pharmacol..
[49] Haptoglobin Therapy Prevents Kidney Injury in Stored Blood Resuscitation of Murine Hemorrhagic Shock , 2014 .
[50] K. Nath. Heme oxygenase-1 and acute kidney injury , 2014, Current opinion in nephrology and hypertension.
[51] F. Hsiao,et al. Safety of deferasirox: a retrospective cohort study on the risks of gastrointestinal, liver and renal events , 2014, Pharmacoepidemiology and drug safety.
[52] A. Kamal,et al. Macrophage and epithelial cell H-ferritin expression regulates renal inflammation , 2015, Kidney international.
[53] D. Leaf,et al. Increased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgery. , 2015, Kidney international.
[54] D. Leaf,et al. Intraoperative High-Dose Dexamethasone and Severe AKI after Cardiac Surgery. , 2015, Journal of the American Society of Nephrology : JASN.
[55] D. Leaf,et al. Length Polymorphisms in Heme Oxygenase-1 and AKI after Cardiac Surgery. , 2016, Journal of the American Society of Nephrology : JASN.
[56] D. Swinkels,et al. Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders , 2016, Haematologica.